Morton Coleman
Hematology & Oncology · New York, NYNPI 1851460406
Payments from drug & device makers
Across 1,113 payments — averaging $7179.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beigene, Ltd.$4.8M
- Bristol Myers Squibb$888K
- Acerta Pharma LLC$801K
- Incyte Corporation$444K
- Eli Lilly$199K
- Seagen Inc.$134K
- plus $680K from 27 others
Across 8 payments — averaging $2898.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$19K
- Bristol Myers Squibb$3K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
What the payments were for
- Consulting fees$12,14414%
- Speaking & faculty fees$57,86569%
- Travel & lodging$12,72015%
- Food & beverage$1,3642%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beigene, Ltd. | 389 | $4,845,707 |
| Bristol Myers Squibb | 13 | $887,808 |
| Acerta Pharma LLC | 41 | $801,306 |
| Incyte Corporation | 392 | $443,541 |
| Eli Lilly | 9 | $198,592 |
| Seagen Inc. | 33 | $134,249 |
| AstraZeneca | 18 | $129,986 |
| Genentech, Inc. | 18 | $101,561 |
| Novartis | 14 | $90,185 |
| Pharmacyclics LLC, An Abbvie Company | 40 | $37,644 |
| Puma Biotechnology, Inc. | 23 | $37,447 |
| Ipsen Bioscience Inc. | 7 | $28,399 |
| GSK | 4 | $21,800 |
| Astrazeneca UK Limited | 3 | $21,633 |
| Array Biopharma Inc | 4 | $20,750 |
| F. Hoffmann-la Roche AG | 8 | $20,658 |
| Hoffmann-la Roche Limited | 1 | $20,230 |
| Gilead(2 entities) | 17 | $19,295 |
| Napo Pharmaceuticals Inc | 1 | $17,250 |
| Veru Inc. | 2 | $15,250 |
| Otsuka Pharmaceutical Co., Ltd. | 1 | $15,000 |
| Johnson & Johnson | 23 | $14,940 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $12,818 |
| Bayer | 16 | $12,662 |
| Mirati Therapeutics, Inc. | 5 | $10,750 |
| Epizyme, Inc. | 5 | $7,428 |
| Beone Medicines Ltd. | 6 | $6,829 |
| EMD Serono, Inc. | 1 | $5,505 |
| E.r. Squibb & Sons, L.L.C. | 4 | $5,383 |
| Amgen | 4 | $3,662 |
| Pfizer | 1 | $1,273 |
| Merck | 1 | $1,000 |
| Karyopharm Therapeutics Inc. | 1 | $500 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,991,041 in reported general payments places this provider in the 95th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in New York
- Vicky MakkerNew York$27.1M
- Alison MoskowitzNew York$22.7M
- Ajai ChariNew York$22.4M
- Yelena JanjigianNew York$16.9M
- Alexander LesokhinNew York$11.9M
- John MascarenhasNew York$11.8M
- Maria PalombaNew York$11.6M
- Scott TagawaNew York$10.3M
- Mohammad Abdul HayNew York$9.9M
- Joshua SabariNew York$9.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.